Afynia

1 known investors

Afynia develops diagnostic technology for endometriosis, a condition affecting approximately 1 in 10 women of reproductive age, which causes chronic pelvic pain and impacts fertility. The company addresses the significant diagnostic delay that worsens patient outcomes across physical, emotional, and social dimensions.